NEW YORK, June 14, 2018 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT uniquely focused on collaborative life science and technology campuses in AAA innovation cluster locations, celebrated the first anniversary of Alexandria LaunchLabs®, which opened at the Alexandria Center® for Life Science – New York City in June 2017. In honor of this milestone, Alexandria will award the second annual $100,000 Alexandria LaunchLabs Seed Capital Prize today to one of 25 emerging innovators and entrepreneurs presenting their biomedical innovations and technologies at the NYC Life Science Innovation Showcase. Hosted at the Alexandria Center – NYC, the showcase is an annual event organized by Alexandria in partnership with the New York Academic Consortium to provide entrepreneurial scientists from NYC's world-renowned academic medical institutions the opportunity to pitch their technology to biopharma executives, investors and other community stakeholders.
Since opening its doors at the Alexandria Center just one year ago, Alexandria LaunchLabs has proven the significant advantages it offers early-stage companies. Alexandria LaunchLabs is currently home to over 20 cutting-edge life science startups selected from a competitive pool of over 175 applicants, many of which have spun out from NYC's leading academic medical institutions. In its first year of operations, Alexandria LaunchLabs grew the number of its member companies by 150%; hosted more than 100 company and community-building events; created multiple touchpoints for its members to engage with fellow entrepreneurs and companies across the Alexandria Center campus; and launched the Alexandria Seed Capital Platform, an innovative funding model to catalyze seed-stage life science investment.
"Our successful execution of Alexandria LaunchLabs and the Alexandria Seed Capital Platform is fostering the city's next generation of best-in-class biotech companies, and it's rewarding to see our full-service startup platform deliver right out of the gate," said Blake Stevens, Ph.D., head of Alexandria LaunchLabs – NYC. "We've created a differentiated platform to accelerate the growth of our member companies by integrating them into a vibrant campus ecosystem with unparalleled access to seed capital, state-of-the-art laboratory expansion space, mentorship and Alexandria's global network."
Led by Alexandria Venture Investments and supported by a deeply experienced advisory board of biopharma and venture executives from AbbVie, Accelerator Life Science Partners, ARCH Venture Partners, Eli Lilly, Pfizer and Roche, the Alexandria Seed Capital Platform offers a high level of engagement intentionally designed to enhance the trajectory of its recipient seed-stage companies. Alexandria has made initial seed-stage investments through the platform and continues to cultivate the local community of seed-stage investors to help catalyze early investment in NYC's most promising life science startups.
"The Alexandria Seed Capital Platform has paved the way for raising early-stage capital through its direct investment and guidance on fundraising strategies," said Charlotte D'Hulst, Ph.D., founder and CEO of MouSensor, Inc., an early-stage biotech company developing a novel and potentially transformative platform to digitize the sense of smell and one of the Alexandria Seed Capital Platform's first investments. "Alexandria has also been instrumental in introducing us to other investors as well as members of its broader network to support our growth."
In addition to attracting locally sourced life science startups, Alexandria LaunchLabs' prime campus location with critical adjacency to NYC's renowned academic and medical institutions has attracted companies from across the country and internationally, including Vienna-, Paris- and Milan-based startups, that are seeking to establish operations in NYC.
By offering affordable startup space, coupled with highly curated services, access to seed capital and a scalable path for companies to expand within the Alexandria Center campus, Alexandria LaunchLabs is solidifying a pipeline of best-in-class startups that will sustain the future growth of NYC's life science ecosystem.
Building upon the success of Alexandria LaunchLabs' initial flagship site in NYC and the Alexandria Seed Capital Platform, Alexandria LaunchLabs will expand to Cambridge, Massachusetts, in the fall of 2018 to meet the cluster's critical demand for life science startup space and access to seed capital.
About Alexandria LaunchLabs®
Alexandria LaunchLabs is the premier, full-service startup platform designed to dramatically accelerate the growth of early-stage life science startups. With its flagship site at the Alexandria Center® for Life Science – New York City and its Cambridge site at the Alexandria Center® at One Kendall Square, Alexandria LaunchLabs provides move-in ready office/laboratory space, first-class support resources, shared equipment and services, creative amenities and access to startup capital through the Alexandria Seed Capital Platform— all of which are critical for driving the growth of seed- and early-stage companies across the country. The Alexandria LaunchLabs team is currently accepting applications for future members in New York City and Cambridge. For more information or to apply, please visit www.alexandrialaunchlabs.com.
- Shared wet laboratory and office spaces, starting at $1,995 per month
- Full-service operations and management
- Strategic programming and mentorship
- Connectivity with Alexandria's robust life science network
- Access to seed capital
- Shared laboratory equipment
- Comprehensive IT/AV package
- Open lounge and conferencing spaces
- Access to Alexandria Center campus amenities and services
About Alexandria Venture Investments
Alexandria Venture Investments, founded in 1996, is the strategic venture capital arm of Alexandria Real Estate Equities, Inc. Alexandria Venture Investments focuses on novel, breakthrough discoveries in biopharma, diagnostics, research tools, agtech and technology. Based on its experience and in-depth understanding of the life science and technology industries, its long-term relationships with leading investors and its world-class scientific advisory network, Alexandria Venture Investments is uniquely positioned to fund seed-, early- and growth-stage companies.
About Alexandria Real Estate Equities, Inc.
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500® company, is an urban office REIT uniquely focused on collaborative life science and technology campuses in AAA innovation cluster locations, with a total market capitalization of $17.9 billion and an asset base in North America of 30.2 million SF as of March 31, 2018. The asset base in North America includes 20.8 million RSF of operating properties and 3.5 million RSF of development and redevelopment of new Class A properties currently undergoing construction and pre-construction activities with target delivery dates ranging from 2018 through 2020. Additionally, the asset base in North America includes 5.9 million SF of intermediate-term and future development projects, including 3.6 million SF of intermediate-term development projects. Founded in 1994, Alexandria pioneered this niche and has since established a significant market presence in key locations, including Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland and Research Triangle Park. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science and technology campuses that provide its innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity and success. For additional information, please visit www.are.com.
CONTACT: Sara Kabakoff, Senior Manager – Corporate Communications, Alexandria Real Estate Equities, Inc., (626) 788-5578
SOURCE Alexandria Real Estate Equities, Inc.